STATE OF WISCONSIN
CONTROLLED SUBSTANCES BOARD
---------------------------------------------------------------------------------------------------------------------
IN THE MATTER OF RULE-MAKING : AFFIRMATIVE ACTION
PROCEEDINGS BEFORE THE : ORDER OF THE
CONTROLLED SUBSTANCES BOARD : CONTROLLED SUBSTANCES BOARD
---------------------------------------------------------------------------------------------------------------------
FINDINGS
1. On August 29, 2006, the Department of Justice, Drug Enforcement Administration published its final rule in the Federal Register listing Embutramide into schedule III of the federal Controlled Substances Act. The scheduling action is effective September 28, 2006.
2. The Controlled Substances Board did not receive an objection to similarly listing Embutramide as a schedule III under ch. 961, Stats. within 30 days of the date of publication in the federal register of the final order listing Embutramide as a schedule III controlled substance. 3. The Controlled Substances Board will promulgate a final rule, without making the determinations or findings required by ss. 961.11(1), (1m), (1r) and (2) or s. 961.17 and omitting the notice of proposed rulemaking, listing Embutramide as a schedule III controlled substance. ORDER
Pursuant to s. 961.11(4), Stats., the Controlled Substances Board by affirmative action similarly treats Embutramide under chapter 961, Stats. by creating the following: CSB 2.87 Addition of Embutramide to schedule III. Section 961.18 (3) (bm), Stats., is created to read:
961.18 (3) (bm) Embutramide.
This order shall take effect upon publication in the Administrative Register. The order expires upon promulgation of a final rule.Dated 7/9/2021 _______________________
Doug Englebert, Chair
Controlled Substances Board
